HALBERT JON has filed 4 insider transactions across 1 company since February 2025.
Most recent transaction: a grant/award of 2492 shares of Caris Life Sciences, Inc. ($CAI) on February 26, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | Caris Life Sciences, Inc. | $CAI | HALBERT JON | Director | A | Common Stock | 2492 | $20.06 | 1,368,621.0000 | 297,211,838 | 0.18% | 0.00% |
| Feb. 27, 2025 | Caris Life Sciences, Inc. | $CAI | HALBERT JON | Director | A | Common Stock | 16129 | $0.00 | 1,366,129.0000 | 35,643,589 | 1.19% | 0.05% |
| June 20, 2025 | Caris Life Sciences, Inc. | $CAI | HALBERT JON | Director | C | Common Stock | 1250000 | $0.00 | 1,366,129.0000 | 35,643,589 | 1076.39% | 3.51% |
| June 20, 2025 | Caris Life Sciences, Inc. | $CAI | HALBERT JON | Director | C | Series A Preferred Stock | 5000000 | $0.00 | 0.0000 | 35,643,589 | 100.00% | 14.03% |